Article Information
History
- May 30, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Koen Degeling1,2,*,
- Nancy N. Baxter2,
- Jon Emery3,
- Fanny Franchini1,2,4,
- Peter Gibbs5,6,
- G. Bruce Mann7,
- Grant McArthur8,9,
- Benjamin J. Solomon8,9 and
- Maarten J. IJzerman1,2,4,10
- 1Centre for Cancer Research and Centre for Health Policy, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia
- 2Melbourne School of Public and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia
- 3Centre for Cancer Research and Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia
- 4Department of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia
- 5Walter and Eliza Hall Research Institute, Division of Personalised Oncology, Melbourne, Australia
- 6Department Medical Oncology, Western Health, Melbourne, Australia
- 7Department of Surgery, University of Melbourne, Melbourne, Australia
- 8Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
- 9Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
- 10Health Technology and Services Research, Technical Medical Centre, Faculty of Behavioural, Management and Social Sciences, University of Twente, Enschede, the Netherlands
- ↵*Corresponding author; email: koen.degeling{at}unimelb.edu.au
Posted May 30, 2020.
An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic
